Notably, only ten percent of CX3CR1-expressing cells migrate to its soluble fractalkine ligand [18], suggesting that the mechanisms behind CX3CR1-driven cancer proliferation goes beyond ligand-mediated chemotaxis. Here, CX3CR1 is linked to cancer.